Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated July 27, 2026, June 12, 2026, May 12, 2026 and April 22, 2026 (the "Prior News Releases"), it has closed a fourth tranche (the "Fourth Tranche") of its previously announced non-brokered private placement (the "Offering"), which Fourth Tranche consisted of the issuance of 8,600,000 units (each, a "Unit") of the Company at a price of $0.025 per Unit for gross aggregate proceeds of $215,000. The Company closed an initial tranche on May 12, 2026 consisting of the issuance of 13,600,000 Units for gross proceeds of $340,000, a second tranche on June 12, 2026 consisting of the issuance of 9,800,000 Units for gross proceeds of $245,000 and a third tranche on July 27, 2026 consisting of the issuance of 8,000,000 Units for gross proceeds of $200,000.